Cancer patients support but don’t understand clinical trials

Cancer patients struggle with some of the fundamentals of clinical trial design such as randomisation – calling into question their ability to provide informed consent. According to research presented at the ESMO 2017 Congress, almost all patients (98.3%) considered clinical trials important but they were hazy on the details. The multi-centre Irish study surveyed more ...

Already a member?

Login to keep reading.

© 2022 the limbic